Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in parkinson's disease. Control Clin Trials. 2002;23(2):111-26.Putt ME, Ravina B. Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in ...
a prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of snz tribac, a three-strain 文档格式: .pdf 文档大小: 404.76K 文档页数: 8页 顶/踩数: 0/0 收藏人数: 0 评论次数: ...
This multicentre, double-blind, placebo-controlled, parallel-group study determined the efficacy and safety of GW660511 200 mg, a dual inhibitor of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP), in mild-to-moderate hypertensive patients (diastolic blood pressure (DBP), 90 and...
Multicenter, double- blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC ... Jeremy R. Johnson MB ChB a,Mary Burnell-Nugent MB BChir b,Dominique Lossignol MB ChB, MRCG, DRCOG c,... - 《J Pain Symptom Manage...
METHODS: A double-blind, randomized, placebo-controlled, parallel study with a 2-week placebo run-in phase followed by a 4-week intervention phase was conducted at ten clinical centers (USA). Subjects were recruited from the general population by advertisement. The study randomized 302 subjects ...
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety & Tolerability of Two Doses of ACT-128800,... This study will assess the efficacy, safety and tolerability of two doses of ACT 128800 in patients with moderate-to-severe chronic ...
controlled, parallel-group clinical trial was conducted. A total of 36 healthy middle-aged participants received one capsule of either 125 mg NMN or placebo twice a day. Among the NAD+metabolites, the levels of nicotinamide in the serum were significantly higher in the NMN intake group than in...
Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel- group study. ...
A randomized, double-blind, placebo-controlled, parallel-group study was conducted to evaluate the efficacy and safety of gabapentin in relieving the symptoms of panic disorder. One hundred three patients were randomly assigned to receive double-blind treatment with either gabapentin (dosed flexibly bet...
This phase 3 study was a 36-week multicenter, randomized, double-blind, placebo-controlled parallel-group clinical trial. Participants with mild-to-moderate AD were assigned randomly (1:1 ratio), to receive GV-971 (450 mg, b.i.d.) or placebo. The trial protocol was approved by the Et...